Plasma serotonin concentrations increase or decrease in stress responses1. The aim of the study was to evaluate serotonin concentrations in different degrees of lameness due to chronic joint disorders in horses undergoing analgesic therapy with tapentadol. PROT. No. 20/CESA /2023. Thirty horses were selected in this study. The orthopedic examination included flexion tests, radiological and ultrasound examinations. The degree of ameness due to chronic osteoarthritis (OA) has been estimated from 0 to 5 according to the American Association of Equine Practitioners (AAEP)2. The horses were divided into group C (control group): healthy horses (n = 10), group A, horses with chronic OA, grade 3-4 lameness (n = 10); Group B, horses with chronic OA, grade 5 (n10) lameness. Heart rate (HR), respiratory rate (RR), systolic (PS), diastolic (PD) and mean (PM) blood pressure were recorded and the serotonin concentration was determined, at baseline and at the beginning of every week for three weeks. Subjects suffering from OA were treated with Tapentadol at a dose of 0.5 mg/kg. The response to painful stimulus on flexion tests was assessed using the NRS (modified Numeric Pain Rating Scale 0-7) from baseline and the CPS (Cumulative Pain score 0-4) after the first week of treatment with tapentadol. Scores were assigned to the percentage changes, compared to baseline, in heart rate, respiratory rate and systolic blood pressure according to the following PS and the score of 10 was the cut-off point for satisfactory analgesic therapy. The degree of lameness decreased along the time line in both groups (score from 3-4 to 1 in group A and score from 5 to 1in group B) p<0.05. The NRS score decreased along the time sequence in both groups p<0.05, respectively from mild pain to no pain in group A (score 1-3 to 0) and from moderate pain to no pain in group B (score from 4 to 0). Physiological variables did not change along the time line. CPS scores ranged from 0.5 to 4 in group A and 1.5 to 7 respectively in group B p=0.008. Serotonin concentrations remained unchanged across the time line in all groups p=1.000 but OA groups were lower than control p=0.000. Tapentadol has been shown to be effective in the management of chronic OA pain in horses and serotonin may be a biomarker in the stress response.

Plasma serotonin concentration biomarker of stress responses in chronic joint disorders undergoing analgesic therapy with tapentadol in horse: preliminary results

Costa, Giovanna Lucrezia
Primo
;
Bruschetta, Giuseppe
Secondo
;
Interlandi, Claudia;Spadola, Filippo;Leonardi, F.;Tabbi', Marco;Bruno, Fabio;Iannelli, Nicola;Licata, Patrizia;Macri', Francesco
Penultimo
;
2024-01-01

Abstract

Plasma serotonin concentrations increase or decrease in stress responses1. The aim of the study was to evaluate serotonin concentrations in different degrees of lameness due to chronic joint disorders in horses undergoing analgesic therapy with tapentadol. PROT. No. 20/CESA /2023. Thirty horses were selected in this study. The orthopedic examination included flexion tests, radiological and ultrasound examinations. The degree of ameness due to chronic osteoarthritis (OA) has been estimated from 0 to 5 according to the American Association of Equine Practitioners (AAEP)2. The horses were divided into group C (control group): healthy horses (n = 10), group A, horses with chronic OA, grade 3-4 lameness (n = 10); Group B, horses with chronic OA, grade 5 (n10) lameness. Heart rate (HR), respiratory rate (RR), systolic (PS), diastolic (PD) and mean (PM) blood pressure were recorded and the serotonin concentration was determined, at baseline and at the beginning of every week for three weeks. Subjects suffering from OA were treated with Tapentadol at a dose of 0.5 mg/kg. The response to painful stimulus on flexion tests was assessed using the NRS (modified Numeric Pain Rating Scale 0-7) from baseline and the CPS (Cumulative Pain score 0-4) after the first week of treatment with tapentadol. Scores were assigned to the percentage changes, compared to baseline, in heart rate, respiratory rate and systolic blood pressure according to the following PS and the score of 10 was the cut-off point for satisfactory analgesic therapy. The degree of lameness decreased along the time line in both groups (score from 3-4 to 1 in group A and score from 5 to 1in group B) p<0.05. The NRS score decreased along the time sequence in both groups p<0.05, respectively from mild pain to no pain in group A (score 1-3 to 0) and from moderate pain to no pain in group B (score from 4 to 0). Physiological variables did not change along the time line. CPS scores ranged from 0.5 to 4 in group A and 1.5 to 7 respectively in group B p=0.008. Serotonin concentrations remained unchanged across the time line in all groups p=1.000 but OA groups were lower than control p=0.000. Tapentadol has been shown to be effective in the management of chronic OA pain in horses and serotonin may be a biomarker in the stress response.
2024
9788890909269
File in questo prodotto:
File Dimensione Formato  
SISVET ATTI 2024 (1)-4.pdf

solo utenti autorizzati

Descrizione: Abstract convegno
Tipologia: Versione Editoriale (PDF)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 147.71 kB
Formato Adobe PDF
147.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
77-CONVEGNO-SISVET-1-6.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.2 MB
Formato Adobe PDF
2.2 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3366158
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact